Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-alpha therapy

Rheumatology International

Volumn 30, Issue 8, 2010, Pages 1125-1129

  Gasparyan, Armen Yuri ^a   Sandoo, Aamer ^a   Stavropoulos Kalinoglou, Antonios ^a   Kitas, George D ^a,b  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anti TNF alpha therapy; Inflammation; Mean platelet volume; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; STATIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TREATMENT OUTCOME;

AGED; ARTHRITIS, RHEUMATOID; BLOOD PLATELETS; BLOOD SEDIMENTATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLATELET COUNT; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954424901     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1345-1     Document Type: Article

References (31)

1. GD Kitas N Erb 2003 Tackling ischaemic heart disease in rheumatoid arthritis Rheumatology (Oxford) 42 607 613 10.1093/rheumatology/keg175 1:STN:280:DC%2BD3s7ptVOguw%3D%3D (Pubitemid 37220867)
2. KM Douglas AV Pace GJ Treharne A Saratzis P Nightingale N Erb MJ Banks GD Kitas 2006 Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome Ann Rheum Dis 65 348 353 10.1136/ard.2005.037978 1:STN:280:DC%2BD28%2FosFWisw%3D%3D 16079169 (Pubitemid 43268224)
3. H Maradit-Kremers PJ Nicola CS Crowson KV Ballman SE Gabriel 2005 Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum 52 722 732 10.1002/art.20878 15751097 (Pubitemid 40365093)
4. VF Panoulas GS Metsios AV Pace H John GJ Treharne MJ Banks GD Kitas 2008 Hypertension in rheumatoid arthritis Rheumatology 47 1286 1298 10.1093/rheumatology/ken159 1:STN:280:DC%2BD1crivFChtA%3D%3D 18467370
5. Toms TE, Symmons DP, Kitas GD (2010) Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol, 1 Jan 2010 [Epub ahead of print]
6. A Stavropoulos-Kalinoglou GS Metsios VF Panoulas KM Douglas AM Nevill AZ Jamurtas M Kita Y Koutedakis GD Kitas 2009 Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis Ann Rheum Dis 68 242 245 10.1136/ard.2008. 095596 1:STN:280:DC%2BD1M%2FmsV2rtg%3D%3D 18677010
7. GS Metsios A Stavropoulos-Kalinoglou JJ Veldhuijzen van Zanten GJ Treharne VF Panoulas KM Douglas Y Koutedakis GD Kitas 2008 Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review Rheumatology (Oxford) 47 239 248 10.1093/rheumatology/kem260 1:STN:280:DC%2BD1c7hsFGhsg%3D%3D (Pubitemid 351267186)
8. PA Bacon RJ Stevens DM Carruthers SP Young GD Kitas 2002 Accelerated atherogenesis in autoimmune rheumatic diseases Autoimmun Rev 1 338 347 10.1016/S1568-9972(02)00100-3 1:CAS:528:DC%2BD38XpsVSqt78%3D 12848989 (Pubitemid 38340246)
9. P Emery C Gabay M Kraan J Gomez-Reino 2007 Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis Rheumatol Int 27 793 806 10.1007/s00296-007-0357-y 1:CAS:528:DC%2BD2sXmtlGkt7s%3D 17505829 (Pubitemid 46906651)
10. D Hürlimann A Forster G Noll F Enseleit R Chenevard O Distler M Béchir LE Spieker M Neidhart BA Michel RE Gay TF Lüscher S Gay F Ruschitzka 2002 Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2184 2187 10.1161/01.CIR.0000037521.71373.44 12390945 (Pubitemid 35222210)
11. F Wolfe K Michaud 2004 Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy Am J Med 116 305 311 10.1016/j.amjmed.2003.09.039 14984815 (Pubitemid 38230289)
12. I Chung A Choudhury GY Lip 2007 Platelet activation in acute, decompensated congestive heart failure Thromb Res 120 709 713 10.1016/j.thromres.2007.01.003 1:CAS:528:DC%2BD2sXpsFKrtrc%3D 17287016 (Pubitemid 47268050)
13. F Ingegnoli F Fantini EG Favalli A Soldi S Griffini V Galbiati PL Meroni M Cugno 2008 Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade J Autoimmun 31 175 179 10.1016/j.jaut.2008.07.002 1:CAS:528:DC%2BD1cXhtVymsb3M 18707846
14. NG Arvidson A Larsen J Aaseth A Larsson 2007 Short-term effects of the TNFalpha antagonist infliximab on the acute phase reaction and activities of daily life in patients with rheumatoid arthritis Scand J Clin Lab Invest 67 337 342 10.1080/00365510601075903 1:CAS:528:DC%2BD2sXmvVGqtbo%3D 17454848 (Pubitemid 46643388)
15. MA Gonzalez-Gay MT Garcia-Unzueta C Gonzalez-Juanatey JA Miranda-Filloy TR Vazquez-Rodriguez JM De Matias J Martin PH Dessein J Llorca 2008 Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis Clin Exp Rheumatol 26 311 316 1:STN:280:DC%2BD1czpvFyrtg%3D%3D 18565254
16. M Milovanovic E Nilsson P Järemo 2004 Relationships between platelets and inflammatory markers in rheumatoid arthritis Clin Chim Acta 343 237 240 10.1016/j.cccn.2003.12.030 1:CAS:528:DC%2BD2cXjs1aqsrk%3D 15115702 (Pubitemid 38534523)
17. B Kisacik A Tufan U Kalyoncu O Karadag A Akdogan MA Ozturk S Kiraz I Ertenli M Calguneri 2008 Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis Joint Bone Spine 75 291 294 10.1016/j.jbspin.2007.06.016 18403245
18. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
19. National Institute of Clinical Excellence (2007) Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis. http://www.nice.org. uk/nicemedia/pdf/TA130guidance.pdf
20. ML Prevoo MA van't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 10.1002/art. 1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D 7818570
21. MS Dastjerdi T Emami A Najafian M Amini 2006 Mean platelet volume measurement, EDTA or citrate? Hematology 11 317 319 10.1080/10245330600954163 17607580 (Pubitemid 46957653)
22. R Caporali FB Pallavicini M Filippini R Gorla A Marchesoni EG Favalli P Sarzi-Puttini F Atzeni C Montecucco 2009 Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal Autoimmun Rev 8 274 280 10.1016/j.autrev.2008.11.003 1:CAS:528:DC%2BD1MXmtVyltLc%3D 19017546
23. MA Gonzalez-Gay C Gonzalez-Juanatey JA Miranda-Filloy C Garcia-Porrua J Llorca J Martin 2006 Cardiovascular disease in rheumatoid arthritis Biomed Pharmacother 60 673 677 10.1016/j.biopha.2006.09.006 1:CAS:528: DC%2BD28Xht1Ohur7K 17049201 (Pubitemid 44821707)
24. M Buttarello M Plebani 2008 Automated blood cell counts: state of the art Am J Clin Pathol 130 104 116 10.1309/EK3C7CTDKNVPXVTN 18550479
25. PM Bath RJ Butterworth 1996 Platelet size: measurement, physiology and vascular disease Blood Coagul Fibrinolysis 7 157 161 10.1097/00001721-199603000- 00011 1:CAS:528:DyaK28XjvFOrtro%3D 8735807
26. P Bath C Algert N Chapman 2004 Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease Stroke 35 622 626 10.1161/01.STR. 0000116105.26237.EC 14976328 (Pubitemid 38280830)
27. MB Yilmaz G Cihan Y Guray U Guray HL Kisacik H Sasmaz S Korkmaz 2008 Role of mean platelet volume in triagging acute coronary syndromes J Thromb Thrombolysis 26 49 54 10.1007/s11239-007-0078-9 17705053
28. N Papanas G Symeonidis E Maltezos G Mavridis E Karavageli T Vosnakidis G Lakasas 2004 Mean platelet volume in patients with type 2 diabetes mellitus Platelets 15 475 478 10.1080/0953710042000267707 1:CAS:528:DC%2BD2cXhtVarsrvO 15763888 (Pubitemid 39656855)
29. CJ Boos GD Beevers GY Lip 2007 Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension Ann Med 39 72 78 10.1080/07853890601040063 17364453
30. Y Tavil N Sen HU Yazici F Hizal A Abaci A Cengel 2007 Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease Thromb Res 120 245 250 10.1016/j.thromres.2006.10.005 1:CAS:528:DC%2BD2sXlsFKgtr8%3D 17145074 (Pubitemid 46759554)
31. E Coban B Afacan 2008 The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment Platelets 19 111 114 10.1080/09537100701230444 1:CAS:528:DC%2BD1cXit1Clsbc%3D 17852772 (Pubitemid 351302381)